How does Zinbryta work?
Medically reviewed by Drugs.com Last updated on Sep 10, 2019.
Official Answerby Drugs.com
Zinbryta is thought to work by decreasing T-cells and pro-inflammatory lymphoid tissue inducer cells, and increasing CD56bright natural killer (NK) cells, important cells that help regulate the immune system.
In studies, patients using Zinbryta had fewer clinical relapses than patients taking placebo or another multiple sclerosis (MS) treatment Avonex (interferon beta-1a).
In May 2016, the FDA approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple sclerosis (MS).
In March 2018, Biogen and AbbVie announced the voluntary worldwide withdrawal of Zinbryta for relapsing multiple sclerosis.
Related Medical Questions
- What are the new drugs used for multiple sclerosis (MS)?
- What types of MS does Ocrevus treat?
- What are the side effects of marijuana?
- Prednisone vs Prednisolone - What's the difference?
- Can people with end stage renal disease take Mayzent?
- How long do you take Mayzent for?
- Zinbryta Information for Consumers
- Zinbryta Information for Healthcare Professionals (includes dosage details)
- Side Effects of Zinbryta (detailed)